The Korea Fair Trade Commission has detected signs that Daewoong Pharmaceutical unfairly supported its group affiliates and has launched an on-site investigation.
According to industry sources on the 31st, the Fair Trade Commission sent investigators to Daewoong Pharmaceutical the previous day to secure materials related to unfair internal support.
The Fair Trade Commission has recently been monitoring internal transactions within mid-sized business groups and has identified allegations of unfair internal transactions by multiple companies, leading to ongoing investigations.
At the beginning of the year, the Fair Trade Commission announced in its work plan that it would focus on closely monitoring illicit wealth transfers for management succession, unfair support that undermines the competitiveness of independent and small businesses, and unfair support of insolvent affiliates.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
